MedTech's European Money Map: what investors are betting on in 2026.
A founder's guide to European investors funding medtech in 2026, what they back, and what they want to see before they write the cheque.
Read more
What Dovetail’s Envoy Service Is, Why It's Different, and Why It's Working
At Dovetail, we believe in human judgement alongside brilliant AI. AI has brought unbridled efficiency to our work and intelligence to our fingertips that was previously inaccessible. You could have it build any document with the right context. It’s enough to do just about anything. But not everything. It
Introducing our new collaboration suite
We built our own AI-native collaboration suite, and the conversation now includes the Dovetail agent. It reads every comment and redline in your document and acts on it, right inside your ISO 13485 quality system. A huge time saver for teams, and it's available now for all users.
An agent that gets smarter where it counts: your device, your regulatory journey, and all of our experience.
Dovetail's agent learns from the decisions, facts, and expert feedback in your calls and written work, not just chats. It remembers what matters, keeps getting better for you, and keeps your data private.
Crossing the Atlantic? Four Things Every UK Medtech Founder Must Pack Before Facing the FDA.
America turns 250 this year. For UK medtech, the US market is still the market worth crossing an ocean for. Standing at the door to the US market is the FDA, and (surprise!) it works nothing like the MHRA or a Notified Body.
